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Endophilin is a recently discovered src homology 3
domain-containing protein that is a major in vitro bind-
ing partner for synaptojanin. To further characterize
endophilin, we generated an antipeptide antibody. En-
dophilin is enriched in the brain, and immunofluores-
cence analysis reveals a high concentration of the pro-
tein in synaptic terminals, where it colocalizes with
synaptojanin. In vitro binding assays demonstrate that
endophilin binds through its src homology 3 domain to
synaptojanin, and immunoprecipitation analysis with
the antiendophilin antibody reveals that endophilin is
stably associated with synaptojanin in the nerve termi-
nal. Immunoprecipitation with an antibody against am-
phiphysin I and II, which interact through their src
homology 3 domains with dynamin and synaptojanin at
sites distinct from those for endophilin, reveals a second
stable complex, which includes dynamin and synaptoja-
nin but excludes endophilin. These data demonstrate
that synaptojanin is present in two separate complexes
in the nerve terminal and support an important role for
endophilin in the regulation of synaptojanin function.
The accuracy and speed of information processing in the
nervous system is critically dependent on “fast” synaptic trans-
mission. At the presynaptic level, there are two key events
underlying this process: the exocytosis of synaptic vesicles from
the nerve terminal, resulting in neurotransmitter release, and
the endocytosis of synaptic vesicle membranes, which restores
the releasable vesicle pool. Although knowledge of the molecu-
lar mechanisms underlying exocytosis has advanced consider-
ably in recent years, the process of endocytosis is still poorly
understood.
One of the few molecules with an established function in
endocytosis is the GTPase dynamin, which participates in the
fission of endocytic vesicles (for review, see Ref. 1). The role of
dynamin in endocytosis was first predicted by studies on the
Drosophila shibire mutant in which mutations of Drosophila
dynamin lead to a block of synaptic vesicle endocytosis (2, 3).
Furthermore, mutations in the GTPase domain of mammalian
dynamin inhibit receptor-mediated endocytosis when overex-
pressed in fibroblasts (4–6). The C terminus of dynamin con-
tains a proline-rich region that interacts with proteins contain-
ing Src homology 3 (SH3) domains (7). An important SH3
domain-containing binding partner for dynamin is amphiphy-
sin I (8, 9). Amphiphysin I is enriched in nerve terminals and is
homologous to the yeast proteins RVS161 and RVS167 (10),
mutations in which cause endocytic defects (11). The SH3 do-
main-mediated interaction between dynamin and amphiphysin
I appears to be an essential step in the endocytosis of synaptic
vesicles, serving to target dynamin to clathrin-coated pits (12,
13). In the nerve terminal, amphiphysin I is likely targeted to
these endocytic sites through SH3 domain-independent inter-
actions with the clathrin adaptor protein 2 (AP2) (8, 14). Re-
cently, we and others have identified a novel amphiphysin
isoform, referred to as amphiphysin II, that also binds through
its SH3 domain to dynamin (15–18). Both amphiphysin I and II
also interact with clathrin, which is likely to contribute to
amphiphysin targeting to the endocytic machinery (17).
Several other proteins besides dynamin and the am-
phiphysins have been implicated in endocytosis, although
compelling evidence for their roles is still lacking. Synapto-
janin is a nerve terminal-enriched protein, which, like dy-
namin, binds to the amphiphysin I and II SH3 domains and
undergoes dephosphorylation upon synaptic terminal depo-
larization (17, 19–21). Synaptojanin is an inositol 5-phospha-
tase with activity against a number of substrates, including
inositol 1,4,5-trisphosphate, insitol 1,3,4,5-tetrakisphos-
phate, phosphatidylinositol 4,5-bisphosphate, and phosphati-
dylinositol 3,4,5-trisphosphate (21, 22), and inositol phos-
phate metabolism is implicated in a variety of membrane
trafficking events, including endocytosis (23). The N-termi-
nal domain of synaptojanin is similar to the cytosolic domain
of the yeast protein SAC1, which has been implicated in
vesicular trafficking, likely via alterations in phospholipid
metabolism and diacylglycerol production (24). The C termi-
nus of synaptojanin is proline-rich and binds to the SH3
domains of amphiphysin I and II.
Recently, another SH3 domain-containing protein, SH3P4
(25), was identified as a major binding partner for synaptojanin
(26). We had independently isolated SH3P4 as a member of a
novel SH3 domain-containing family of proteins with unknown
function using an expression library screen with an SH3 do-
main peptide ligand (25). In the current study, we determined
that SH3P4 is brain specific and is enriched in the presynaptic
nerve terminal. Using in vitro binding assays, we determined
that SH3P4, amphiphysin I, and amphiphysin II each bind to
distinct sites within the proline-rich tail of synaptojanin, and
the three proteins can bind to synaptojanin simultaneously.
However, immunoprecipitation analysis revealed that, in situ,
two separate and stable synaptojanin complexes are formed:
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synaptojanin with SH3P4, and synaptojanin with amphiphysin
I or II and dynamin. These results suggest an important role
for SH3P4 in synaptic vesicle endocytosis, possibly through
regulating the recruitment of synaptojanin to the site of endo-
cytosis, and we thus renamed SH3P4 as endophilin.
EXPERIMENTAL PROCEDURES
Antibodies—Polyclonal antiendophilin antibodies (1903 and 1904)
were made against an 18-residue peptide (residues 256–272, CQPK-
PRMSLEFATGDSTQ), synthesized at the W. M. Keck Biotechnology
Resource Laboratory at Yale University (New Haven, CT), and conju-
gated to KLH (Calbiochem) as described (27). The conjugated peptide
was injected into rabbits (approximately 600 mg per rabbit) using Ti-
termax adjuvant (CytRx Corp.) with standard protocols. Antibodies
were affinity purified from sera against strips of polyvinylidene difluo-
ride membrane (BioRad) containing the peptide conjugated to bovine
serum albumin as described (28). Polyclonal antibodies against am-
phiphysin and synaptojanin were described previously (8, 17, 20, 26).
The following antibodies were generous gifts: a monoclonal antibody
against synaptojanin (Drs. Amy Hudson and Pietro De Camilli, Yale
University); a polyclonal antisynapsin antibody (G246, Dr. Pietro De
Camilli, Yale University) (29); a polyclonal antisynaptophysin antibody
(Dr. Reinhard Jahn, Yale University) (30). The monoclonal antibody
against dynamin (Hudy I) was purchased from Upstate Biotechnology
Inc. Western blot analysis was performed as described previously (31).
Analysis of Tissue and Subcellular Distribution—Postnuclear super-
natants from different tissues were prepared and processed for Western
blots as described (17). The subcellular distribution of endophilin in
various regions of the rat brain was studied on frozen sections by
immunofluorescence as described (17).
Production of Fusion Proteins—Endophilin in pEXlox(1) vector (25)
was used as a template in PCRs1 with Vent DNA Polymerase (New
England Biolabs) to generate the following GST fusion proteins: full-
length endophilin (amino acid residues 1–352), the N-terminal domain
of endophilin (residues 1–291), and the SH3 domain of endophilin
(residues 292–352). The full-length endophilin was prepared with the
forward primer 59-GCGGGATCCATGTCGGTGGCAGGGCTG (Fa) and
the reverse primer 59-GCGGAATTCTCAATGGGGCAGAGCAACCAG
(Ra). For the N-terminal domain, the same forward primer was used
(Fa) with the reverse primer 59-GCGGAATTCTCACATTTGGACACCT-
GGAGG (Rb). For the SH3 domain, the forward primer 59-GCGGGATC-
CGATCAGCCCTGCTGCCG (Fb) was used with the reverse primer Ra
were used. The PCR products were cloned in frame into the BamHI–
EcoRI sites of pGEX-2TK (Pharmacia) and the GST fusion proteins
were expressed and purified as described (19).
Amphiphysin I and amphiphysin II GST fusion proteins were pre-
pared as described (17).
Affinity Chromatography—Rat brain postnuclear supernatants, pre-
pared as described (17), were incubated with 1% Triton X-100 for 1 h at
4 °C, and insoluble material was removed by centrifugation in a Beck-
man 50Ti rotor at 45,000 rpm for 1 h. The supernatant was diluted to
2 mg/ml of protein in 20 mM HEPES-OH, pH 7.4, containing 0.83 mM
benzamidine, 0.23 mM phenylmethylsulfonyl fluoride, 0.5 mg/ml apro-
tinin, 0.5 mg/ml leupeptin, and 1% Triton X-100 (Buffer A), and 1-ml
aliquots were incubated overnight at 4 °C with the GST fusion proteins
described above (approximately 25 mg/ml of each protein) prebound to
glutathione-Sepharose. After incubation, samples were washed three
times in 1 ml of buffer, and bound proteins were eluted with SDS-PAGE
sample buffer and prepared for Western blot analysis.
Overlay Assays—Nitrocellulose membranes with protein fractions
purified by endophilin affinity chromatography were incubated over-
night at 4 °C in Tris-buffered saline (50 mM Tris-Cl, pH 8.3, 150 mM
NaCl) containing 3% bovine serum albumin, 0.1% Tween-20, 1 mM
dithiothreitol, and 500,000 cpm/ml of phosphorylated full-length en-
dophilin GST fusion protein. The fusion protein was phosphorylated
with heart muscle protein kinase (Sigma) following the protocol sup-
plied by the manufacturer of the pGEX-2TK vector (Pharmacia). Trans-
fers were then washed three times for 5 min each in Tris-buffered saline
and exposed to film.
For the overlay assays on synaptojanin, full-length synaptojanin and
a synaptojanin deletion mutant lacking the 231-amino acid proline-rich
C terminus (synaptojanin R-2) were purified from Spodoptera frugi-
perda (Sf9) cells after baculovirus-mediated expression as described
(26). To construct a synaptojanin deletion mutant lacking the last 127
amino acids of the proline-rich C terminus, PCR was performed on a
full-length synaptojanin cDNA (clone 9) (21) with Vent DNA polymer-
ase. The forward primer (59-GGTGATGTCGACGACTAC) corresponds
to nucleotides 3178–3195 spanning a SalI site, and the reverse primer,
R-1 (59-GCGGTCGACAAGCTTTTATGCAAGTCCGGCTTGAGG) corre-
sponds to nucleotides 3619–3636 and encodes a SalI site flanking a
HindIII site. The PCR product was digested with SalI and subcloned
into SalI-digested clone 9, generating clone Bluescript R-1. This clone
was digested with HindIII, and the liberated fragment was subcloned
into HindIII-digested clone 1B7 (prepared as described in Ref. 26),
generating clone synaptojanin R-1. For synaptojanin 170, PCR was
performed on clone 9 with Vent DNA polymerase using the forward
primer 59-GCGAAGCTTGGTAAAAATAAATGGAGCTTG, correspond-
ing to nucleotides 4026–4046, and the reverse primer 59-GCGAAG-
CTTTTATCTTTCTGTGAAGTCCAATG, corresponding to nucleotides
4821–4799. The PCR product was digested with HindIII and subcloned
into the second HindIII site of clone synaptojanin (26) after a partial
HindIII digestion. The clones were packaged into baculovirus and used
to infect Sf9 cells, and the expressed proteins were purified as described
(26). Approximately 1 mg each of the various synaptojanin proteins were
run on SDS-PAGE, transferred to nitrocellulose, and overlaid with
GST-endophilin, GST-amphiphysin I, GST-amphiphysin II, or GST
alone as described (19).
Binding Assays—A (His)6-endophilin fusion protein was prepared by
digesting the pGEX-2TK plasmid containing full-length endophilin,
prepared as described above, with BamHI and EcoRI and ligating the
liberated fragment into the BamHI–EcoRI sites of pTrcHisA (Invitro-
gen). The (His)6 fusion protein was expressed and purified as recom-
mended for the QIA express system using Ni-NTA resin (Qiagen). To
examine the interactions of endophilin and amphiphysin with synapto-
janin and dynamin, approximately 2 mg of GST fusion proteins of the
SH3 domains of amphiphysin I or amphiphysin II, precoupled to glu-
tathione-Sepharose beads, were incubated with 1 mg of purified synap-
tojanin or dynamin and increasing concentrations of purified (His)6/
endophilin. Dynamin was purified from Sf9 cells after baculovirus-
induced expression as described (32) and was a generous gift of Dr.
Sandra Schmid (Scripps Research Institute). The reactions were carried
out in 1 ml of Buffer A for 4 h at 4 °C. For all binding assays, at the end
of the incubations, the beads were pelleted by microcentrifugation,
washed three times in 1 ml of Buffer A, resuspended in SDS sample
buffer, and prepared for Western blot analysis.
Immunoprecipitation—A crude synaptosomal fraction (P29) was pre-
pared from rat brain as described (33). It was resuspended in a buffer
containing 10 mM HEPES-OH, pH 7.4, 150 mM NaCl, 1 mM EGTA, 0.83
mM benzamidine, 0.23 mM phenylmethylsulfonyl fluoride, 0.5 mg/ml
aprotinin, and 0.5 mg/ml leupeptin (Buffer B). The samples were then
homogenized with a Polytron, Triton X-100 was added to a final con-
centration of 0.1%, and the samples were incubated for 20 min at 4 °C
before removing insoluble material by centrifugation at 75,000 rpm for
15 min in a Beckman TLA 100.2 rotor. The supernatant was precleared
with protein A-Sepharose and was then incubated for 2 h at 4 °C with
antiendophilin (1903) or antiamphiphysin sera (1874) precoupled to
protein A-Sepharose. Finally, samples were washed three times with 1
ml of Buffer B containing 0.1% Triton X-100 and were eluted with SDS
sample buffer.
RESULTS
Endophilin Is a Brain-specific Protein, Concentrated in Syn-
aptic Terminals—To further characterize endophilin, we gen-
erated polyclonal rabbit antisera (1903 and 1904) against a
peptide sequence specific to the protein. After affinity purifica-
tion, both antibodies recognized a single 40-kDa band on strips
of crude brain homogenate (data not shown). Endophilin has a
predicted molecular mass of 39,880 Da (25). When tested on
immunoblots from a variety of tissues, endophilin immunore-
activity was observed only in brain (Fig. 1).
We next examined the subcellular localization of endophilin
on frozen sections from rat brain using immunofluorescence.
Endophilin immunoreactivity had a predominantly punctate
appearance, indicative of a concentration of the antigen in
presynaptic nerve terminals (Fig. 2, A and B). There was also a
relatively high level of immunoreactivity in the cytoplasm of
cell bodies. Cell nuclei were immunonegative, as were axons.
The pattern of endophilin immunoreactivity looked very simi-
1 The abbreviations used are: PCR, polymerase chain reaction; GST,
glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis.
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lar to that of synaptojanin, as well as the synaptic markers
synapsin (Fig. 2B) and synaptophysin (data not shown). Inter-
estingly, endophilin, like synaptojanin, appeared to be absent
from mossy fiber axon terminals in the CA3 region of the
hippocampus (Fig. 2B), which was the only brain region exam-
ined where endophilin and synaptojanin did not co-localize
with known synaptic markers.
Endophilin Binds to Several Brain Proteins, Including Syn-
aptojanin and Dynamin—To identify binding partners of en-
dophilin, we performed affinity chromatography on crude rat
brain extracts using a full-length endophilin GST fusion pro-
tein. We then overlaid the column elution fraction with radio-
labeled endophilin and observed three major bands at 145, 135,
and 100 kDa (Fig. 3A). Western blots of the elution fractions
identified the 145- and 100-kDa bands as synaptojanin and
dynamin, respectively (Fig. 3B). The identity of the 135-kDa
endophilin-binding protein remains unknown. To further de-
lineate the interactions, affinity chromatography was per-
formed using GST fusion proteins encoding the N-terminal and
the SH3 domains of endophilin, and both synaptojanin and
dynamin were found to specifically bind to the SH3 domain
(Fig. 3B).
Endophilin, Amphiphysin I, and Amphiphysin II Bind to
Different Sites in the Proline-rich C Terminus of Synaptoja-
nin—In addition to endophilin, synaptojanin can also bind to
amphiphysin I (8) and amphiphysin II (17). To begin to deter-
mine the sites of interaction on synaptojanin for these three
proteins, the 170-kDa isoform of synaptojanin (34), as well as
the 145-kDa isoform and two deletion constructs lacking the
last 127 amino acids of the proline-rich C terminus (synapto-
janin R-1) or the entire 231 amino acid proline-rich C terminus
(synaptojanin R-2), were purified from Sf9 cells after baculovi-
rus-mediated expression. Western blot analysis confirmed an
equal loading of each protein (Fig. 4). These constructs were
then overlaid with GST fusion proteins containing either the
SH3 domain of endophilin, amphiphysin I, or amphiphysin II.
GST alone did not interact with any of the synaptojanin pro-
teins (Fig. 4). In contrast, endophilin and amphiphysin I SH3
domain fusion proteins bound to the 170- and 145-kDa isoforms
of synaptojanin and to synaptojanin R-1 but did not bind to
synaptojanin R-2. Thus, there is a binding site(s) for the SH3
domains of endophilin and amphiphysin I between amino acids
1061 and 1165 of synaptojanin. Interestingly, the amphiphysin
II SH3 domain did not bind to synaptojanin R-1 or R-2, indi-
cating that the binding site for this protein lies between amino
acids 1165 and 1276. These results suggested that endophilin
and amphiphysin I bind proline-rich sequence(s) in the same
region of synaptojanin that is different from the binding site of
amphiphysin II.
To further characterize the interactions between these pro-
teins, we incubated GST fusion proteins encoding the SH3
domains of amphiphysin I or amphiphysin II, prebound to
glutathione-Sepharose beads, with constant amounts of syn-
aptojanin in the presence of increasing concentrations of
(His)6/endophilin. In both cases, the formation of a complex of
endophilin, synaptojanin, and the amphiphysin isoform was
observed (Fig. 5) suggesting that the amphiphysin isoforms
bind to proline-rich sequences distinct from the endophilin
binding site. Coupled with the results from Fig. 4, these data
suggest that the three proteins each interact with a unique
site within the proline-rich tail of synaptojanin. Only when
endophilin was in large excess to synaptojanin was a slight
decrease in the binding of synaptojanin to amphiphysin I or
II observed, possibly due to nonspecific binding of endophilin
to the amphiphysin I and II binding sites (Fig. 5).
Amphiphysin I or II and Endophilin Can Interact Simulta-
neously with Dynamin—Like synaptojanin, dynamin can bind
to amphiphysin I (8), amphiphysin II (17), and endophilin. To
determine whether these interactions can occur simulta-
neously, we incubated GST fusion proteins of the amphiphysin
I or II SH3 domains, precoupled to glutathione-Sepharose, with
a constant amount of dynamin and increasing concentrations of
(His)6/endophilin. As was the case for synaptojanin, the forma-
tion of a complex of endophilin and dynamin with either am-
phiphysin isoform was observed (Fig. 5). At high concentrations
of endophilin, the amount of bound endophilin reached satura-
tion. At the highest concentration of endophilin (100 mg/ml), a
decreased amount of dynamin was detected in the precipitate,
probably due, as in the case of synaptojanin, to nonspecific
binding of endophilin to the amphiphysin I and II binding sites.
These results indicate that, like synaptojanin, dynamin inter-
acts with its SH3-binding partners via distinct proline-rich
sequences.
In Situ, Endophilin and the Amphiphysin Isoforms Form
Two Separate Complexes with Synaptojanin—To investigate
the interactions of endophilin and the amphiphysins with syn-
aptojanin and dynamin in situ, we performed immunoprecipi-
tations from rat brain synaptosomes. The antiendophilin anti-
serum strongly immunoprecipitated endophilin (Fig. 6).
Synaptojanin co-immunoprecipitated with endophilin and was
similarly enriched in the precipitate compared with the start-
ing material. Neither dynamin nor amphiphysin I or II co-
immunoprecipitated with endophilin under these conditions.
We then used an antiamphiphysin antiserum that recognizes
amphiphysin I and II. The two amphiphysin isoforms were
enriched in the immunoprecipitate (Fig. 6). Interestingly, both
synaptojanin and dynamin co-immunoprecipitated with the
amphiphysins, but no endophilin was detected. It thus appears
that endophilin and the two amphiphysin isoforms form two
separate complexes with synaptojanin in situ: endophilin with
synaptojanin; amphiphysin I or II with synaptojanin and
dynamin.
DISCUSSION
Endophilin, a member of a novel family of three SH3 domain-
containing proteins (endophilin (also known as SH3P4),
SH3P8, and SH3P13) (25) was recently identified as a major
synaptojanin-binding partner in brain (26). Using an antipep-
tide antibody, we now demonstrate that endophilin is brain
specific and is concentrated in synaptic terminals throughout
FIG. 1. Tissue distribution of endophilin. Proteins from post-
nuclear supernatants of various rat tissues (100 mg per lane) were
separated by SDS-PAGE, transferred to nitrocellulose, and processed
for Western blot with the affinity-purified polyclonal antibody against
endophilin. The antibody was revealed with a 4-chloro-1-naphthol-
based color development as described previously (31).
Synaptojanin Protein Complexes 27241
the brain, where it colocalizes with synaptojanin, dynamin, and
amphiphysin I and II (8, 17). One exception to this synaptic
localization is in the mossy fiber nerve terminals in the CA3
region of the hippocampus, where neither synaptojanin, en-
dophilin, nor dynamin is detectable, whereas common synaptic
markers, such as synapsin and synaptophysin, are present at
high levels. This peculiar absence or very low level of endocytic
proteins is well correlated with the low firing rates of the
granule cells that give rise to these terminals (35). Moreover,
the mossy fibers form large terminals, densely packed with
synaptic vesicles (36), which also implies a very low demand for
endocytic restoration of the vesicle pool. Thus, the tissue and
subcellular distribution of endophilin further support a role for
endophilin in endocytosis.
The interaction between endophilin and synaptojanin is me-
diated via the endophilin SH3 domain, and synaptojanin can
also bind to the SH3 domains of amphiphysin I and II (8, 17).
Overlay assays of synaptojanin deletion constructs revealed
that endophilin and amphiphysin I interact with synaptojanin
between amino acids 1061 and 1165, a region comprising sev-
eral consensus SH3 domain-binding sites. One such site (PXR-
PXR; amino acids 1065–1070) was recently identified as the
binding site for amphiphysin I on dynamin (9, 37). Meanwhile,
amphiphysin II was found to bind between amino acids 1165
and 1276 of synaptojanin, indicating that amphiphysin II uti-
lizes a distinct binding site. In fact, binding experiments using
purified recombinant proteins demonstrated that amphiphysin
I, amphiphysin II, and endophilin can interact simultaneously
with synaptojanin without competing for binding sites, sug-
gesting that all three proteins interact at distinct sites. These
FIG. 2. Localization of endophilin in
the rat brain by immunofluores-
cence. A, frozen sections from rat brain
cerebellum and brainstem were immuno-
reacted with antibodies against endophi-
lin and synaptojanin. Note the predomi-
nantly punctate appearance of endophilin
immunoreactivity, especially surrounding
the cell bodies, which is indicative of a
concentration of endophilin in presynap-
tic nerve terminals. The molecular layer
of the cerebellum, which is rich in synap-
tic terminals, is also brightly stained. In
contrast, the axonal bundles passing
through the brainstem are essentially
void of labeling. This pattern closely re-
sembles the synaptojanin immunoreactiv-
ity. M, molecular layer; P, Purkinje cell
layer; G, granule cell layer. Scale bar, 50
mm. B, endophilin, synaptojanin, and syn-
apsin immunoreactivity in the CA1 and
CA3 regions of the rat brain hippocam-
pus. The mossy fiber terminals (p), which
are brightly stained by the synapsin anti-
body, do not display endophilin and syn-
aptojanin immunolabeling. Meanwhile, in
other regions of the hippocampus, as else-
where in the brain, the staining patterns
for these three proteins were similar and
were indicative of a presynaptic enrich-
ment. Scale bar, 50 mm.
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observations further confirm the specificity of the SH3 domain-
mediated interactions (38) and raise the interesting possibility
of the existence in the nerve terminal of a larger protein com-
plex formed through simultaneous interactions of several SH3
proteins with the proline-rich tail of synaptojanin.
In addition to synaptojanin, endophilin was also found to
bind in an SH3 domain-dependent manner to dynamin, a nerve
terminal-enriched protein whose involvement in endocytosis is
supported by a wealth of data (reviewed in Ref. 1). Dynamin
has a proline-rich C terminus that mediates its binding to a
number of SH3 domain-containing proteins in vitro, such as
phopholipase Cg, Grb2, the regulatory subunit of phosphati-
dylinositol 3-kinase (p85a) (7) and amphiphysin I and II (8, 9,
17, 37). However, among these potential binding partners, only
amphiphysin I and II are concentrated in synaptic terminals.
Recent evidence showing that disruption of the interaction
between dynamin and amphiphysin I inhibits endocytosis in
nerve terminals (13) confirms the importance of the dynamin/
amphiphysin I association in vivo. We have now identified
another SH3 domain-binding partner for dynamin, which, like
amphiphysin I and II, is enriched in nerve terminals and may
also represent a physiological partner for dynamin. Further-
more, dynamin, like synaptojanin, appears to contain distinct
proline-rich binding sites for its different SH3 domain partners
and is able to interact simultaneously with several of these
proteins.
The present in vitro results reveal that the SH3 domain-
containing proteins endophilin and amphiphysin I and II have
the potential to bind the proline-rich regions of both synapto-
janin and dynamin in vivo. To investigate the interactions
between these proteins occurring in situ, we performed immu-
noprecipitations from crude rat brain synaptosome fractions
using antiendophilin and antiamphiphysin antibodies. The re-
sults indicate that two separate and stable complexes are
formed in the nerve terminal: synaptojanin with endophilin,
and synaptojanin with amphiphysin I or II and dynamin. The
exact nature of this second complex is still unknown. Regard-
less, the immunoprecipitation results give an important indi-
cation for the stable physiological interactions taking place in
the nerve terminal. Meanwhile, these results do not exclude
the possibility that other interactions that were observed in
vitro may also take place, although such interactions might be
more transient, possibly limited to certain stages of the synap-
tic vesicle cycle within the nerve terminal.
Thus, two distinct and stable protein complexes appear to
exist in the nerve terminal: amphiphysin I and II with synap-
tojanin and dynamin, and endophilin with synaptojanin. The
amphiphysin-containing complex is well suited for targeting of
synaptojanin and dynamin to sites of endocytosis. For example,
amphiphysin I binds to the plasmalemmal clathrin adaptor
protein AP2 (8, 14), and both amphiphysin I and II bind to
clathrin (17). It is, indeed, known that the SH3 domain-medi-
ated interaction between amphiphysin I and dynamin is essen-
tial for recruiting dynamin to clathrin-coated pits (12, 13). By a
similar mechanism, amphiphysin I and/or II may also partici-
FIG. 3. Identification of the major binding partners of endophilin. A, nitrocellulose membranes with protein fractions purified by
endophilin affinity chromatography were overlaid with radiolabeled endophilin. Three major bands, at 145, 135, and 100 kDa were observed. B,
left, Triton X-100-soluble proteins from rat brain were incubated with a GST fusion protein encoding full-length endophilin conjugated to
glutathione-Sepharose. The material bound to the beads was eluted with SDS sample buffer (beads), separated on SDS-PAGE along with aliquots
of the soluble starting material (SM) and unbound material (void), transferred to nitrocellulose, and immunoblotted with synaptojanin, dynamin,
and synaptophysin antibodies. B, right, Triton X-100-soluble proteins were incubated with GST fusion proteins encoding the N-terminal domain
or the SH3 domain of endophilin conjugated to glutathione-Sepharose. The material bound to the beads was eluted with SDS sample buffer,
separated on SDS-PAGE (N-terminal domain and SH3 domain) along with aliquots of the soluble starting material (SM), and processed for
Western blots. The synaptophysin antibody was revealed with a 4-chloro-1-naphthol-based color development as described previously (31), and the
dynamin and synaptojanin antibodies were revealed with ECL (Amersham Corp.).
FIG. 4. Endophilin, amphiphysin I, and amphiphysin II bind-
ing to synaptojanin constructs. The 170-kDa (p170) and 145-kDa
(p145) isoforms of synaptojanin and two deletion constructs lacking the
last 127 amino acids of the proline-rich C terminus (synaptojanin R-1)
(R-1) or the entire 231-amino acid proline-rich C terminus (synaptoja-
nin R-2) (R-2) were purified from Sf9 cells after baculovirus-mediated
expression. Nitrocellulose membranes with approximately 1 mg of each
of the proteins were immunoblotted with a synaptojanin antibody di-
rected against its N terminus (1852 Western) and a synaptojanin anti-
body directed against a region of its C terminus (Milo Western), or
overlaid with GST-endophilin, GST-amphiphysin I, GST-amphiphysin
II, or GST alone. The Western blots were revealed with ECL (Amer-
sham Corp.), and the overlays were revealed with a 4-chloro-1-naph-
thol-based color development.
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pate in the targeting of synaptojanin. Once at clathrin-coated
pits, synaptojanin, through its 5-phosphatase activity (21, 22),
might function in regulating endocytosis by decreasing the
local concentrations of inositol phosphates, which inhibit AP2-
and AP3-mediated clathrin assembly (39, 40). Alternatively,
synaptojanin could function in the regulation of phospholipase
D activity and the formation of phosphatidic acid (41), or it
could play a role in endocytosis through rearrangement of actin
filaments (42). Less is known about the possible roles of the
endophilin/synaptojanin complex. This complex might serve to
regulate the amount of synaptojanin at the sites of endocytosis
by limiting the pool of synaptojanin available for interaction
with the amphiphysin isoforms. Alternatively, endophilin
might not simply buffer excess synaptojanin but rather actively
target it to other sites within the neuron, possibly through its
central domain, which has a high probability of participating in
coiled-coil interactions. Synaptojanin, dynamin, and am-
phiphysin I are known to undergo dephosphorylation upon
nerve terminal depolarization (20, 43–45), and this may ac-
count for an activity-dependent regulation of the interactions
within and between the two endocytic complexes. Whatever the
mechanism, the present results provide strong evidence for the
involvement of endophilin in synaptic vesicle endocytosis.
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